danazol has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, CA; Huang, J; Li, CY; Mesa, RA; Pardanani, A; Tefferi, A; Wu, W | 1 |
| MartÃn Casellas, E; Salinas Argente, R; Sans-Sabrafen, J | 1 |
2 other study(ies) available for danazol and Leukemia
| Article | Year |
|---|---|
Risk factors for leukemic transformation in patients with primary myelofibrosis.
Topics: Cell Transformation, Neoplastic; Danazol; Erythropoietin; Female; Humans; Leukemia; Male; Middle Aged; Primary Myelofibrosis; Risk Factors | 2008 |
[Danazol in the treatment of acute leukemic transformation of myelodysplastic syndromes].
Topics: Acute Disease; Aged; Danazol; Humans; Leukemia; Male; Myelodysplastic Syndromes; Pregnadienes | 1987 |